Théo was born with serious laryngeal and esophageal malformations, requiring 55 surgeries and a tracheostomy, which have led to ongoing health challenges.

Sabine Grataloup, Théo's mother, has expressed frustration over the European Union's decision to renew glyphosate's approval, criticizing lawmakers for their lack of awareness regarding its risks.

Bayer denies any causal link between glyphosate and Théo's condition, asserting that the herbicide has no reproductive effects, a claim supported by various scientific studies.

The family initiated legal action in 2018 to establish a connection between glyphosate exposure and Théo's malformations, a significant shift from previous lawsuits that primarily focused on cancer claims.

After six years of legal battles, the Grataloup family views this trial as a crucial step in their long fight for justice and recognition of the harm caused by glyphosate.

The Grataloup family is suing Bayer, the current owner of Monsanto, claiming that glyphosate, a widely used herbicide, caused severe malformations in their son, Théo, who was born in May 2007.

In October 2023, the Pesticide Victims Compensation Fund recognized a possible link between Théo's disabilities and his mother's glyphosate exposure during pregnancy, providing him with monthly compensation.

This landmark trial, which is set to begin on April 3, 2025, at the judicial court of Vienne in France, marks the first case globally linking glyphosate exposure to birth defects.

Sabine likened their struggle to 'David versus Goliath,' as Bayer's legal team attempts to deflect responsibility, claiming that other entities within the company should be held accountable.

The court's decision in this case is anticipated on July 31, 2025, which could set a significant legal precedent for future cases involving glyphosate and birth defects.

Since 2011, the Grataloup family has meticulously documented the potential link between glyphosate exposure and malformations, urging public authorities to take protective measures.

Now 17 years old, Théo hopes that the outcome of this trial will pave the way for others with similar conditions to seek justice and accountability.